Evidence map›Paper›PMID 33129292›Full record

ArticleBMC nephrology2020

Association between health-related hope and adherence to prescribed treatment in CKD patients: multicenter cross-sectional study.

Noriaki Kurita, Takafumi Wakita, Yoshitaka Ishibashi, Shino Fujimoto, Masahiko Yazawa, Tomo Suzuki, Kenichiro Koitabashi, Mai Yanagi, Hiroo Kawarazaki, Joseph Green and 2 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Weight Management Experiences Among People With CKD: A Qualitative Study.Canadian journal of kidney health and disease · 2025
    Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Noriaki KuritaDepartment of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan. kuritanoriaki@gmail.com.ORCID 0000-0003-4127-7500
Takafumi WakitaDepartment of Sociology, Kansai University, Osaka, Japan.
Yoshitaka IshibashiDepartment of Nephrology, Japanese Red Cross Medical Center, Tokyo, Japan.
Shino FujimotoDepartment of Nephrology, Japanese Red Cross Medical Center, Tokyo, Japan.
Masahiko YazawaDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Tomo SuzukiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Kenichiro KoitabashiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Mai YanagiDepartment of Nephrology, Japanese Red Cross Medical Center, Tokyo, Japan.
Hiroo KawarazakiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Joseph GreenGraduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shunichi FukuharaCenter for Innovative Research for Communities and Clinical Excellence (CIRC2LE), Fukushima Medical University, Fukushima, Japan.
Yugo ShibagakiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
St. Marianna University School of Medicine · JPJapanese Red Cross Medical Center · JPFukushima Medical University · JPKansai University · JPThe University of Tokyo · JP

Funding

Japan Society for the Promotion of Science JP16H05216
6 · The paper itself

Abstract

backgroundIn chronic kidney disease (CKD), patients' adherence to prescriptions for diet and for medications might depend on the degree to which they have hope that they will enjoy life, and that hope could vary with the stage of CKD. The aims of this study were to quantify both the association of CKD stage with health-related hope (HR-Hope), and the association of that hope with psychological and physiological manifestations of adherence.

methodsThis was a cross-sectional study involving 461 adult CKD patients, some of whom were receiving dialysis. The main exposure was HR-Hope, measured using a recently-developed 18-item scale. The outcomes were perceived burden of fluid restriction and of diet restriction, measured using the KDQOL, and physiological manifestations of adherence (systolic and diastolic blood pressure [BP], and serum phosphorus and potassium levels). General linear models and generalized ordered logit models were fit.

resultsParticipants at non-dialysis stage 4 and those at stage 5 had lower HR-Hope scores than did those at stage 2 or 3 (combined). Those at non-dialysis stage 5 had the lowest scores. HR-Hope scores of participants at stage 5D were similar to those of participants at stage 4, but they were lower than the scores of participants at stage 2 or 3 (combined). Higher HR-Hope scores were associated with lower perceived burdens of fluid restriction and of diet restriction (adjusted ORs per ten-point difference were 0.82 and 0.84, respectively). Higher HR-Hope scores were associated with lower systolic BP (adjusted mean difference in systolic BP per ten-point difference in HR-Hope scores was - 1.87 mmHg). In contrast, HR-Hope scores were not associated with diastolic BP, serum phosphorus levels, or serum potassium levels.

conclusionsAmong CKD patients, HR-Hope is associated with disease stage, with psychological burden, and with some physiological manifestations of adherence.

Indexed as

HopePatient ComplianceQuality of LifeAgedBlood PressureCost of IllnessCross-Sectional StudiesFemaleHumansMaleMiddle AgedPhosphorusPotassiumRenal DialysisRenal Insufficiency, ChronicPhosphorusPotassiumAdherenceBlood pressureChronic kidney diseaseDialysisDiet restrictionFluid restrictionHealth-related hopeQuality of life

Identifiers

PMID33129292
PMCPMC7603681
OpenAlexW3094681631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.